Related Experiment Video
Updated: Sep 6, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie1, David Rosmarin2, Michael P Schön3,4
1Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Chronic inflammatory skin diseases affect 20-25% of the population, stemming from genetics, environment, autoimmunity, or rare conditions. Improved diagnostics and targeted therapies are needed to overcome treatment challenges and improve patient outcomes.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Chronic inflammatory skin diseases impact 20-25% of the population.
- Causes include genetics, environmental factors, autoimmunity (T-cell or B-cell driven), autoinflammatory, and rheumatic diseases.
- Common examples include atopic dermatitis, psoriasis, urticaria, lichen planus, and hidradenitis suppurativa.
Purpose of the Study:
- To review the current landscape of chronic inflammatory skin diseases.
- To highlight challenges in diagnosis and treatment.
- To emphasize the need for improved diagnostics and personalized medicine.
Main Methods:
- Review of common and rare chronic inflammatory skin diseases.
- Discussion of etiological factors (genetic, environmental, autoimmune).
- Analysis of current diagnostic and therapeutic approaches and their limitations.
Main Results:
- Significant advancements in diagnosis and treatment exist, yet challenges persist.
- Rarer conditions often suffer from delayed diagnosis due to low awareness and limited diagnostics.
- Systemic immunosuppression is common but associated with adverse events, insufficient response, and relapses.
- Innovative treatments for atopic dermatitis and psoriasis are available, but treatment response prediction is lacking.
Conclusions:
- Development of predictive (bio)markers is crucial for selecting specific medications for individual patients.
- Future developments hold promise for addressing current diagnostic and therapeutic challenges in chronic inflammatory skin diseases.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

